Abstract
Mouse models have been developed to study the pathogenic process of Clostridium difficile infections, first the intestinal colonization and second the toxin production. These models have also been used to test the role of environmental conditions that modulate infection. Different mouse models have been used successfully to study C. difficile infections such as conventional mice, gnotobiotic mouse models including the monoxenic C. difficile mouse model, and the human microbiota-associated mouse model. The advantages and disadvantages of these models are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wilson KH, Sheagren JV and Freter R. (1985) Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis 151, 355–361.
Larson HE and Borriello SP. (1990) Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters. Antimicrob Agents Chemother 34, 1348–1353.
Lucas F, Elmer GW, Brot-Laroche E and Corthier G. (1989) Fixation of Clostridium difficile toxin A and cholera toxin to intestinal brush border membranes from axenic and conventional mice. Infect Immun 57, 1680–1683.
Wilson KH, Sheagren JN, Freter R, Weatherbee L and Lyerly L. (1986) Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. J Infect Dis 153, 547–551.
Borriello SP, Barclay FE and Welch AR. (1988) Evaluation of the predictive capability of an in vitro model of colonization resistance to Clostridium difficile infection. Microb Ecol Health Dis 1, 61–64.
Wilson KH and Perini F. (1988) Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 56, 2610–2614.
Raibaud P, Ducluzeau R, Dubos R, Hudault S, Bewa H and Muller MC. (1980) Implantation of bacteria from the digestive tract of man and various animals in gnotobiotic mice. Am J Clin Nutr 33, 2440–2447.
Onderdonk AB, Cisneros RL and Bartlett JG. (1980) Clostridium difficile in gnotobiotic mice. Infect Immun 28, 277–282.
Corthier G, Dubos F and Raibaud P. (1985) Modulation of cytotoxin production by Clostridium difficile in the intestinal tract of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environm Microbiol 49, 250–252.
Corthier G, Dubos. F and Ducluzeau R. (1986) Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can J Microbiol 32, 894–896.
Corthier G and Muller MC. (1988) Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic one. Infect Immun 56, 1500–1504.
Tasteyre A, Barc MC, Collignon A and Karjalainen T. (2001) Role of flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun 69, 7937–7940.
Ducluzeau R, Ladire M, Callut C, Raibaud P and Abrams GD. (1977) Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice. Infect Immun 17, 415–424.
Boureau H, Decré D, Carlier JP, Guichet C and Bourlioux P. (1993) Identification of a Clostridium cocleatum strain involved in an anti-Clostridium difficile barrier effect and determination of its mucin-degrading enzymes. Res Microbiol 44, 405–410.
Boureau H, Salanon C, Decaens C and Bourlioux P. (1994) Caecal localisation of the specific microbiota resistant to Clostridium difficile colonisation in gnotobiotic mice. Microb Ecol Health Dis 7, 111–117.
Karjalainen T, Ramaldes M, Leblond F, Boureau H and Bourlioux P. (1997) The cloning of sialidase genes from Clostridium indolis and Clostridium cocleatum. Clin Infect Dis 25, S156–S157.
Thomas V, Rochet V, Boureau H, Ekstrand C, Bulteau S, Doré J, Collignon A and Bourlioux P. (2002) Molecular characterization and spatial analysis of a simplified gut microbiota displaying colonization resistance against Clostridium difficile. Microb Ecol Health Dis 14, 203–210.
Hirayama K, Kawamura S and Mitsuoka T. (1991) Development and stability of human fecal flora in the intestine of ex-germ-free mice. Microb Ecol Health Dis 4, 95–99.
Hazenberg MP, Bakker M and Verschoor-Burggraaf A. (1981) Effects of human intestinal microflora on germ-free mice. J Appl Bacteriol 50, 95.
Wong WC, Hentges DJ and Dougherty SH. (1996) Adequacy of the human fecal microbiota associated mouse as a model for studying the ecology of the human intestinal tract. Microbial Ecol Health Dis 9, 187–198.
Imaoka A, Setoyama H, Takagi A, Matsumoto S and Umesaki Y. (2004) Improvement of human faecal flora-associated mouse model for evaluation of the functional foods. J Appl Microbiol 96, 656–663.
Barc MC, Bourlioux F, Rigottier-Gois L, Charrin-Sarnel C, Janoir C, Boureau H, Doré J and Collignon A. (2004) Effect of amoxicillin clavulanic acid on human faecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group specific 16S rRNA probes in combination with flow cytometry. Antimicrob Agents Chemother 48, 1365–1368.
Péchiné S, Janoir C, Boureau H, Gleizes A, Tsapis N, Hoys S, Fattal E and Collignon A. (2007) Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile. Vaccine 25, 3946–3954.
Acknowledgments
The author would like to thank Séverine Péchiné, Alban Le Monnier, and Sandra Hoys for their advice. The author also thanks her colleagues from the U.E.P.S.D., INRA, Jouy-en-Josas, for their help in gnotoxenic experiments and particularly Sylvie Rabot who is responsible for the gnotobiotic animals.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Collignon, A. (2010). Methods for Working with the Mouse Model. In: Mullany, P., Roberts, A.P. (eds) Clostridium difficile. Methods in Molecular Biology™, vol 646. Humana Press. https://doi.org/10.1007/978-1-60327-365-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-60327-365-7_15
Publisher Name: Humana Press
Print ISBN: 978-1-60327-364-0
Online ISBN: 978-1-60327-365-7
eBook Packages: Springer Protocols